Lexapro Shows Better Efficacy Than Cymbalta In Treatment Of Depression
In a class of antipsychotic drugs generic Lexapro is a useful treatment option for treating depression. A new study was conducted and Forest Laboratories, Inc., (NYSE: FRX) today announced the results.
The randomized, double-blinded study involved patients 18-80 years of age with DSM-IV diagnosed MDD as determined by a Montgomery-Asberg Depression Rating Scale (MADRS) score of 26 or greater. The participants were administered to take Lexapro 10mg per day (the dose was increased to 20 mg per day) or Cymbalta antipsychotic medicine 60 mg per day. The period of treatment amounted 8 weeks.
The results of this research showed that after eight weeks Lexapro (Escitalopram).
patients demonstrated greater improvement than Cymbalta patients in total MADRS score. Remission rates were 44 percent in the Lexapro group and 38 percent in the Cymbalta group. However, there was no difference on a number of measures of relief of pain-related and somatic symptoms between the groups.
In addition, Lexapro tablets were better tolerated than Cymbalta, because 87 percent in the Lexapro group completed eight weeks of treatment versus 69 percent in the Cymbalta group and fewer patients receiving Escitalopram generic discontinued treatment due to adverse events compared to patients receiving Cymbalta medication.
Dr. Arif Kahn, Medical Director of Northwest Clinical Research Center and investigator in this study supposes that the results of this study prove once again the clinical value of Lexapro drug in the treatment of depression.
To buy cheap Lexapro order it in our online pharmacy.
